Chemosensitivity testing in gynecologic malignancies and breast cancer: 30 tables
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
Basel [u.a.]
Karger
1994
|
Schriftenreihe: | Contributions to gynecology and obstetrics
19 |
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Beschreibung: | Literaturangaben |
Beschreibung: | X, 199 S. Ill., graph. Darst. |
ISBN: | 3805559496 |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV009810173 | ||
003 | DE-604 | ||
005 | 20190129 | ||
007 | t | ||
008 | 940920s1994 ad|| |||| 00||| eng d | ||
016 | 7 | |a 942166809 |2 DE-101 | |
020 | |a 3805559496 |9 3-8055-5949-6 | ||
035 | |a (OCoLC)243795707 | ||
035 | |a (DE-599)BVBBV009810173 | ||
040 | |a DE-604 |b ger |e rakwb | ||
041 | 0 | |a eng | |
049 | |a DE-19 |a DE-355 |a DE-12 | ||
084 | |a XH 8211 |0 (DE-625)152953:13140 |2 rvk | ||
245 | 1 | 0 | |a Chemosensitivity testing in gynecologic malignancies and breast cancer |b 30 tables |c vol. ed. O. R. Köchli ... |
264 | 1 | |a Basel [u.a.] |b Karger |c 1994 | |
300 | |a X, 199 S. |b Ill., graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a Contributions to gynecology and obstetrics |v 19 | |
500 | |a Literaturangaben | ||
650 | 0 | 7 | |a Cytostatikum |0 (DE-588)4068347-3 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Brustkrebs |0 (DE-588)4008528-4 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Modell |0 (DE-588)4039798-1 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Genitalkrebs |0 (DE-588)4020153-3 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Arzneimittelresistenz |0 (DE-588)4143180-7 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Chemotherapie |0 (DE-588)4127083-6 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Frau |0 (DE-588)4018202-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Gynäkologische Onkologie |0 (DE-588)4022657-8 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
689 | 0 | 0 | |a Gynäkologische Onkologie |0 (DE-588)4022657-8 |D s |
689 | 0 | 1 | |a Chemotherapie |0 (DE-588)4127083-6 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Brustkrebs |0 (DE-588)4008528-4 |D s |
689 | 1 | 1 | |a Chemotherapie |0 (DE-588)4127083-6 |D s |
689 | 1 | |5 DE-604 | |
689 | 2 | 0 | |a Frau |0 (DE-588)4018202-2 |D s |
689 | 2 | 1 | |a Genitalkrebs |0 (DE-588)4020153-3 |D s |
689 | 2 | 2 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
689 | 2 | 3 | |a Arzneimittelresistenz |0 (DE-588)4143180-7 |D s |
689 | 2 | |5 DE-604 | |
689 | 3 | 0 | |a Brustkrebs |0 (DE-588)4008528-4 |D s |
689 | 3 | 1 | |a Chemotherapie |0 (DE-588)4127083-6 |D s |
689 | 3 | 2 | |a Arzneimittelresistenz |0 (DE-588)4143180-7 |D s |
689 | 3 | 3 | |a Modell |0 (DE-588)4039798-1 |D s |
689 | 3 | |5 DE-604 | |
689 | 4 | 0 | |a Gynäkologische Onkologie |0 (DE-588)4022657-8 |D s |
689 | 4 | 1 | |a Chemotherapie |0 (DE-588)4127083-6 |D s |
689 | 4 | 2 | |a Arzneimittelresistenz |0 (DE-588)4143180-7 |D s |
689 | 4 | 3 | |a Modell |0 (DE-588)4039798-1 |D s |
689 | 4 | |5 DE-604 | |
700 | 1 | |a Köchli, Ossi R. |d 20. Jht. |e Sonstige |0 (DE-588)1089195389 |4 oth | |
830 | 0 | |a Contributions to gynecology and obstetrics |v 19 |w (DE-604)BV000003686 |9 19 | |
856 | 4 | 2 | |m DNB Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006492891&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-006492891 |
Datensatz im Suchindex
_version_ | 1807774143611928576 |
---|---|
adam_text |
CONTENTS
FOREWORD
BY
W.P.
MCGUIRE
.
VII
INTRODUCTION
.
IX
OVERVIEW
MULTIMODALITY
THERAPY
IN
GYNECOLOGIC
ONCOLOGY
.
1
SEVIN,
B.-U.
(MIAMI,
FLA.)
OVERVIEW
OF
CURRENTLY
USED
CHEMOSENSITIVITY
TEST
SYSTEMS
IN
GYNECOLOGIC
MALIGNANCIES
AND
BREAST
CANCER
.
12
KOCHLI,
O.R
(ZURICH);
SEVIN,
B.-U.;
AVERETTE,
H.E.
(MIAMI,
FLA.);
HALLER,
U.
(ZURICH)
CHEMOSENSITIVITY
ASSAYS
IN
FRESH
TUMORS
CLONOGENIC
ASSAYS
FOR
GYNECOLOGIC
MALIGNANCIES.
METHODOLOGY
AND
RESULTS
.
24
AAPRO,
M.S.
(GENEVE)
SHORT-TERM
ASSAY
(RADIOLABELED
DNA-PRECURSOR
UPTAKE
METHOD)
IN
GYNECOLOGIC
MALIGNANCIES.
METHODOLOGY
AND
RESULTS
.
30
PETRU,
E.
(GRAZ);
KAUFMANN,
M.
(HEIDELBERG)
USE
OF
THE
EXTREME
DRUG
RESISTANCE
ASSAY
TO
EVALUATE
MECHANISMS
OF
RESISTANCE
IN
OVARIAN
CANCER:
TAXOL
RESISTANCE
AND
MDR-1
EXPRESSION
.
39
FRUEHAUF,
J.P.
(IRVINE,
CALIF.);
MANETTA,
A.
(ORANGE,
CALIF.)
THE
FLUORESCENT
CYTOPRINT
ASSAY
IN
GYNECOLOGICAL
MALIGNANCIES
AND
BREAST
CANCER.
METHODOLOGY
AND
RESULTS
.
53
BLACKMAN,
K.E.
(WARWICK,
R.I.);
FINGERT,
H.J.;
FULLER,
A.F.
(BOSTON,
MASS.);
MEITNER,
P.A.
(WARWICK,
R.I.)
THE
IDENTIFICATION
OF
DRUG
RESISTANCE
IN
OVARIAN
CANCER
AND
BREAST
CANCER:
APPLICATION
OF
THE
MTT
ASSAY
.
64
SARGENT,
J.;
ELGIE,
A.;
TAYLOR,
C.G.;
WILSON,
J.;
ALTON,
P.;
GORDON
HILL,
J.
(PEMBURY,
KENT)
IN
VIVO
CHEMOSENSITIVITY
TEST
MODELS
FOR
GYNECOLOGIC
MALIGNANCIES.
METHODOLOGY
AND
RESULTS
.
76
KLEINE,
W.
(FREIBURG)
CLINICAL
CORRELATIONS
FOR
CELL
CULTURE
ASSAYS
BASED
ON
THE
CONCEPT
OF
TOTAL
TUMOR
CELL
KILL
.
82
WEISENTHAL,
L.M.
(HUNTINGTON
BEACH,
CALIF.)
ASSESSMENT
OF
SYNERGISTIC
AND
ANTAGONISTIC
EFFECTS
OF
CHEMOTHERAPEUTIC
AGENTS
IN
VITRO
.
9J
CHOU,
T.-CH.
(NEW
YORK,
N.Y.)
ATP-CVA
AND
ITS
APPLICATIONS
IN
ONCOLOGY
ATP-CELL
VIABILITY
ASSAY
METHODOLOGY
IN
BOTH
FRESH
GYNECOLOGIC
TUMORS
AND
CELL
LINES
.
108
KOCHLI,
O.R.
(ZURICH);
PERRAS,
J.P.;
SEVIN,
B.-U.
(MIAMI,
FLA.)
IN
VIVO/IN
VITRO
CORRELATION
OF
XENOGRAFTS
IN
NUDE
MICE
AND
ATP-CELL
VIABILITY
ASSAY
.
122
PERRAS,
J.P.
(MIAMI,
FLA.);
HURST,
J.
(PLANTATION,
FLA.)
REVIEW
OF
DATA
ON
GYNECOLOGIC
CANCER
CELL
LINES:
POTENTIAL
APPLICATIONS
OF
ATP-CELL
VIABILITY
ASSAYS
.
132
NGUYEN,
H.N.
(FT.
LAUDERDALE,
FLA.);
SEVIN,
B.-U.;
PERRAS,
J.P.;
AVERETTE,
H.E.
(MIAMI,
FLA.)
EVALUATION
OF
NEW
DRUGS
AND
COMBINATIONS
IN
GYNECOLOGIC
TUMORS
AND
CANCER
CELL
LINES
WITH
THE
ATP-CELL
VIABILITY
ASSAY
.
145
UNTCH,
M.
(MUNCHEN);
SEVIN,
B.-U.
(MIAMI,
FLA.)
APPLICATION
OF
THE
ATP-CELL
VIABILITY
ASSAY
FOR
ASSESSMENT
OF
IN
VITRO
RADIATION
TREATMENT
RESPONSE
IN
GYNECOLOGIC
CANCER
CELL
LINES
.
156
RODRIGUEZ,
M.;
STEREN,
A.J.
(MIAMI,
FLA.)
APPLICATION
OF
THE
ATP-CELL
VIABILITY
ASSAY
FOR
ASSESSMENT
OF
BIOLOGIC
RESPONSE
MODIFIERS
IN
GYNECOLOGIC
CANCER
.
166
ANGIOLI,
R.;
SEVIN,
B.-U.
(MIAMI,
FLA.)
CURRENT
STATUS
AND
FUTURE
DIRECTIONS
OF
CHEMOSENSITIVITY
TESTING
.
179
SEVIN,
B.-U.;
PERRAS,
J.P.
(MIAMI,
FLA.);
KOCHLI,
O.R.
(ZURICH)
SUBJECT
INDEX
.
195
CONTENTS
VI |
any_adam_object | 1 |
author_GND | (DE-588)1089195389 |
building | Verbundindex |
bvnumber | BV009810173 |
classification_rvk | XH 8211 |
ctrlnum | (OCoLC)243795707 (DE-599)BVBBV009810173 |
discipline | Medizin |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 cb4500</leader><controlfield tag="001">BV009810173</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20190129</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">940920s1994 ad|| |||| 00||| eng d</controlfield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">942166809</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3805559496</subfield><subfield code="9">3-8055-5949-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)243795707</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV009810173</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-12</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 8211</subfield><subfield code="0">(DE-625)152953:13140</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Chemosensitivity testing in gynecologic malignancies and breast cancer</subfield><subfield code="b">30 tables</subfield><subfield code="c">vol. ed. O. R. Köchli ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel [u.a.]</subfield><subfield code="b">Karger</subfield><subfield code="c">1994</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">X, 199 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Contributions to gynecology and obstetrics</subfield><subfield code="v">19</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturangaben</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Modell</subfield><subfield code="0">(DE-588)4039798-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Genitalkrebs</subfield><subfield code="0">(DE-588)4020153-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelresistenz</subfield><subfield code="0">(DE-588)4143180-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Frau</subfield><subfield code="0">(DE-588)4018202-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gynäkologische Onkologie</subfield><subfield code="0">(DE-588)4022657-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Gynäkologische Onkologie</subfield><subfield code="0">(DE-588)4022657-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Frau</subfield><subfield code="0">(DE-588)4018202-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Genitalkrebs</subfield><subfield code="0">(DE-588)4020153-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="2"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="3"><subfield code="a">Arzneimittelresistenz</subfield><subfield code="0">(DE-588)4143180-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="1"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="2"><subfield code="a">Arzneimittelresistenz</subfield><subfield code="0">(DE-588)4143180-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="3"><subfield code="a">Modell</subfield><subfield code="0">(DE-588)4039798-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="4" ind2="0"><subfield code="a">Gynäkologische Onkologie</subfield><subfield code="0">(DE-588)4022657-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="4" ind2="1"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="4" ind2="2"><subfield code="a">Arzneimittelresistenz</subfield><subfield code="0">(DE-588)4143180-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="4" ind2="3"><subfield code="a">Modell</subfield><subfield code="0">(DE-588)4039798-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="4" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Köchli, Ossi R.</subfield><subfield code="d">20. Jht.</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)1089195389</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Contributions to gynecology and obstetrics</subfield><subfield code="v">19</subfield><subfield code="w">(DE-604)BV000003686</subfield><subfield code="9">19</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">DNB Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006492891&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-006492891</subfield></datafield></record></collection> |
genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
genre_facet | Aufsatzsammlung |
id | DE-604.BV009810173 |
illustrated | Illustrated |
indexdate | 2024-08-19T00:36:09Z |
institution | BVB |
isbn | 3805559496 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-006492891 |
oclc_num | 243795707 |
open_access_boolean | |
owner | DE-19 DE-BY-UBM DE-355 DE-BY-UBR DE-12 |
owner_facet | DE-19 DE-BY-UBM DE-355 DE-BY-UBR DE-12 |
physical | X, 199 S. Ill., graph. Darst. |
publishDate | 1994 |
publishDateSearch | 1994 |
publishDateSort | 1994 |
publisher | Karger |
record_format | marc |
series | Contributions to gynecology and obstetrics |
series2 | Contributions to gynecology and obstetrics |
spelling | Chemosensitivity testing in gynecologic malignancies and breast cancer 30 tables vol. ed. O. R. Köchli ... Basel [u.a.] Karger 1994 X, 199 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Contributions to gynecology and obstetrics 19 Literaturangaben Cytostatikum (DE-588)4068347-3 gnd rswk-swf Brustkrebs (DE-588)4008528-4 gnd rswk-swf Modell (DE-588)4039798-1 gnd rswk-swf Genitalkrebs (DE-588)4020153-3 gnd rswk-swf Arzneimittelresistenz (DE-588)4143180-7 gnd rswk-swf Chemotherapie (DE-588)4127083-6 gnd rswk-swf Frau (DE-588)4018202-2 gnd rswk-swf Gynäkologische Onkologie (DE-588)4022657-8 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Gynäkologische Onkologie (DE-588)4022657-8 s Chemotherapie (DE-588)4127083-6 s DE-604 Brustkrebs (DE-588)4008528-4 s Frau (DE-588)4018202-2 s Genitalkrebs (DE-588)4020153-3 s Cytostatikum (DE-588)4068347-3 s Arzneimittelresistenz (DE-588)4143180-7 s Modell (DE-588)4039798-1 s Köchli, Ossi R. 20. Jht. Sonstige (DE-588)1089195389 oth Contributions to gynecology and obstetrics 19 (DE-604)BV000003686 19 DNB Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006492891&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Chemosensitivity testing in gynecologic malignancies and breast cancer 30 tables Contributions to gynecology and obstetrics Cytostatikum (DE-588)4068347-3 gnd Brustkrebs (DE-588)4008528-4 gnd Modell (DE-588)4039798-1 gnd Genitalkrebs (DE-588)4020153-3 gnd Arzneimittelresistenz (DE-588)4143180-7 gnd Chemotherapie (DE-588)4127083-6 gnd Frau (DE-588)4018202-2 gnd Gynäkologische Onkologie (DE-588)4022657-8 gnd |
subject_GND | (DE-588)4068347-3 (DE-588)4008528-4 (DE-588)4039798-1 (DE-588)4020153-3 (DE-588)4143180-7 (DE-588)4127083-6 (DE-588)4018202-2 (DE-588)4022657-8 (DE-588)4143413-4 |
title | Chemosensitivity testing in gynecologic malignancies and breast cancer 30 tables |
title_auth | Chemosensitivity testing in gynecologic malignancies and breast cancer 30 tables |
title_exact_search | Chemosensitivity testing in gynecologic malignancies and breast cancer 30 tables |
title_full | Chemosensitivity testing in gynecologic malignancies and breast cancer 30 tables vol. ed. O. R. Köchli ... |
title_fullStr | Chemosensitivity testing in gynecologic malignancies and breast cancer 30 tables vol. ed. O. R. Köchli ... |
title_full_unstemmed | Chemosensitivity testing in gynecologic malignancies and breast cancer 30 tables vol. ed. O. R. Köchli ... |
title_short | Chemosensitivity testing in gynecologic malignancies and breast cancer |
title_sort | chemosensitivity testing in gynecologic malignancies and breast cancer 30 tables |
title_sub | 30 tables |
topic | Cytostatikum (DE-588)4068347-3 gnd Brustkrebs (DE-588)4008528-4 gnd Modell (DE-588)4039798-1 gnd Genitalkrebs (DE-588)4020153-3 gnd Arzneimittelresistenz (DE-588)4143180-7 gnd Chemotherapie (DE-588)4127083-6 gnd Frau (DE-588)4018202-2 gnd Gynäkologische Onkologie (DE-588)4022657-8 gnd |
topic_facet | Cytostatikum Brustkrebs Modell Genitalkrebs Arzneimittelresistenz Chemotherapie Frau Gynäkologische Onkologie Aufsatzsammlung |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006492891&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
volume_link | (DE-604)BV000003686 |
work_keys_str_mv | AT kochliossir chemosensitivitytestingingynecologicmalignanciesandbreastcancer30tables |